Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 92881 | 66.93 |
09:34 ET | 13537 | 66.46 |
09:36 ET | 22523 | 66.14 |
09:38 ET | 42660 | 66.065 |
09:39 ET | 15748 | 66.265 |
09:41 ET | 20349 | 66.0162 |
09:43 ET | 22129 | 65.74 |
09:45 ET | 18782 | 65.83 |
09:48 ET | 6886 | 65.91 |
09:50 ET | 20399 | 65.75 |
09:52 ET | 10854 | 65.758 |
09:54 ET | 16664 | 65.81 |
09:56 ET | 18521 | 65.55 |
09:57 ET | 20388 | 65.42 |
09:59 ET | 16007 | 65.57 |
10:01 ET | 16292 | 65.64 |
10:03 ET | 27318 | 65.29 |
10:06 ET | 7353 | 65.47 |
10:08 ET | 16424 | 65.27 |
10:10 ET | 18030 | 65.06 |
10:12 ET | 82681 | 64.82 |
10:14 ET | 14520 | 64.84 |
10:15 ET | 47341 | 64.75 |
10:17 ET | 10085 | 64.89 |
10:19 ET | 32275 | 64.42 |
10:21 ET | 43701 | 64.5 |
10:24 ET | 73001 | 64.265 |
10:26 ET | 33914 | 64.36 |
10:28 ET | 36031 | 64.2276 |
10:30 ET | 61736 | 63.91 |
10:32 ET | 40700 | 64.17 |
10:33 ET | 10577 | 64.25 |
10:35 ET | 10951 | 64.43 |
10:37 ET | 9089 | 64.53 |
10:39 ET | 11367 | 64.67 |
10:42 ET | 14898 | 64.46 |
10:44 ET | 20070 | 64.63 |
10:46 ET | 13121 | 64.59 |
10:48 ET | 4014 | 64.535133 |
10:50 ET | 9545 | 64.3299 |
10:51 ET | 5310 | 64.31 |
10:53 ET | 18304 | 64.502 |
10:55 ET | 9037 | 64.49 |
10:57 ET | 2599 | 64.44 |
11:00 ET | 12555 | 64.565 |
11:02 ET | 7501 | 64.51 |
11:04 ET | 3625 | 64.41 |
11:06 ET | 5706 | 64.31 |
11:08 ET | 11136 | 64.34 |
11:09 ET | 9325 | 64.2 |
11:11 ET | 6070 | 64.16 |
11:13 ET | 9896 | 64.14 |
11:15 ET | 10296 | 64.07 |
11:18 ET | 18256 | 64.175 |
11:20 ET | 7760 | 64.14 |
11:22 ET | 8591 | 64.14 |
11:24 ET | 11076 | 64.36 |
11:26 ET | 8594 | 64.24 |
11:27 ET | 9118 | 64.19 |
11:29 ET | 8049 | 64.25 |
11:31 ET | 5804 | 64.2859 |
11:33 ET | 7571 | 64.31 |
11:36 ET | 6956 | 64.39 |
11:38 ET | 9180 | 64.32 |
11:40 ET | 17459 | 64.3733 |
11:42 ET | 6877 | 64.4228 |
11:44 ET | 13055 | 64.5 |
11:45 ET | 13710 | 64.445 |
11:47 ET | 15063 | 64.43 |
11:49 ET | 6855 | 64.4433 |
11:51 ET | 17099 | 64.35 |
11:54 ET | 8949 | 64.495 |
11:56 ET | 4782 | 64.5582 |
11:58 ET | 4078 | 64.59 |
12:00 ET | 14720 | 64.72 |
12:02 ET | 8991 | 64.78 |
12:03 ET | 13378 | 64.81 |
12:05 ET | 7324 | 64.88 |
12:07 ET | 11147 | 64.88 |
12:09 ET | 6189 | 64.865 |
12:12 ET | 4161 | 64.955 |
12:14 ET | 15075 | 65.03 |
12:16 ET | 3751 | 64.97 |
12:18 ET | 6450 | 64.93 |
12:20 ET | 26861 | 64.85 |
12:21 ET | 7405 | 64.82 |
12:23 ET | 9293 | 65.05 |
12:25 ET | 3685 | 64.97 |
12:27 ET | 5087 | 64.93 |
12:30 ET | 9546 | 64.925 |
12:32 ET | 3700 | 64.855 |
12:34 ET | 4453 | 64.645 |
12:36 ET | 9643 | 64.72 |
12:38 ET | 3670 | 64.545 |
12:39 ET | 4599 | 64.45 |
12:41 ET | 5796 | 64.32 |
12:43 ET | 4838 | 64.33 |
12:45 ET | 907 | 64.31 |
12:48 ET | 3398 | 64.27 |
12:50 ET | 3698 | 64.31 |
12:52 ET | 4847 | 64.37 |
12:54 ET | 4566 | 64.36 |
12:56 ET | 5724 | 64.51 |
12:57 ET | 7362 | 64.31 |
12:59 ET | 8413 | 64.43 |
01:01 ET | 5290 | 64.2415 |
01:03 ET | 9199 | 64.1797 |
01:06 ET | 10126 | 64.12 |
01:08 ET | 20034 | 64.0806 |
01:10 ET | 10174 | 64.05 |
01:12 ET | 8850 | 64.025 |
01:14 ET | 28580 | 64.02 |
01:15 ET | 29452 | 63.86 |
01:17 ET | 23517 | 63.8 |
01:19 ET | 8181 | 63.8 |
01:21 ET | 13110 | 63.64 |
01:24 ET | 13288 | 63.59 |
01:26 ET | 33331 | 63.55 |
01:28 ET | 16432 | 63.55 |
01:30 ET | 14398 | 63.79 |
01:32 ET | 5869 | 63.638 |
01:33 ET | 10081 | 63.765 |
01:35 ET | 6008 | 63.87 |
01:37 ET | 11393 | 63.86 |
01:39 ET | 10634 | 63.93 |
01:42 ET | 4919 | 63.91 |
01:44 ET | 4872 | 63.9683 |
01:46 ET | 4349 | 64.0687 |
01:48 ET | 6369 | 64.03 |
01:50 ET | 2141 | 64.07 |
01:51 ET | 5334 | 64.09 |
01:53 ET | 2367 | 64.096 |
01:55 ET | 7021 | 64.165 |
01:57 ET | 5629 | 64.3 |
02:00 ET | 4302 | 64.31 |
02:02 ET | 15517 | 64.3402 |
02:04 ET | 18250 | 64.535 |
02:06 ET | 13483 | 64.51 |
02:08 ET | 9014 | 64.5008 |
02:09 ET | 7390 | 64.5 |
02:11 ET | 4611 | 64.4905 |
02:13 ET | 9070 | 64.61 |
02:15 ET | 2611 | 64.57 |
02:18 ET | 4940 | 64.61 |
02:20 ET | 13949 | 64.5137 |
02:22 ET | 4444 | 64.65 |
02:24 ET | 7135 | 64.658 |
02:26 ET | 4537 | 64.56 |
02:27 ET | 6016 | 64.6111 |
02:29 ET | 6046 | 64.64 |
02:31 ET | 5567 | 64.66 |
02:33 ET | 11671 | 64.76 |
02:36 ET | 8147 | 64.725 |
02:38 ET | 7280 | 64.64 |
02:40 ET | 12402 | 64.575 |
02:42 ET | 7748 | 64.585 |
02:44 ET | 8386 | 64.525 |
02:45 ET | 14546 | 64.53 |
02:47 ET | 11001 | 64.48 |
02:49 ET | 7823 | 64.48 |
02:51 ET | 14047 | 64.42 |
02:54 ET | 7348 | 64.37 |
02:56 ET | 20387 | 64.36 |
02:58 ET | 8063 | 64.46 |
03:00 ET | 15126 | 64.48 |
03:02 ET | 8853 | 64.475 |
03:03 ET | 26559 | 64.53 |
03:05 ET | 6025 | 64.6 |
03:07 ET | 7766 | 64.8 |
03:09 ET | 3585 | 64.785 |
03:12 ET | 13349 | 64.83 |
03:14 ET | 4405 | 64.715 |
03:16 ET | 4622 | 64.67 |
03:18 ET | 2763 | 64.6654 |
03:20 ET | 8120 | 64.5499 |
03:21 ET | 6152 | 64.557 |
03:23 ET | 11833 | 64.615 |
03:25 ET | 7095 | 64.565 |
03:27 ET | 5994 | 64.6 |
03:30 ET | 12422 | 64.62 |
03:32 ET | 12339 | 64.46 |
03:34 ET | 18267 | 64.39 |
03:36 ET | 10919 | 64.38 |
03:38 ET | 13454 | 64.29 |
03:39 ET | 31610 | 64.198 |
03:41 ET | 9413 | 64.29 |
03:43 ET | 13488 | 64.31 |
03:45 ET | 14499 | 64.22 |
03:48 ET | 11304 | 64.16 |
03:50 ET | 23688 | 64.07 |
03:52 ET | 20862 | 64.081 |
03:54 ET | 38659 | 63.965 |
03:56 ET | 37960 | 64 |
03:57 ET | 37846 | 63.9206 |
03:59 ET | 721108 | 63.93 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 25.7B | -4.2x | --- |
ICON PLC | 23.8B | 33.1x | +4.68% |
Biontech SE | 28.2B | -51.4x | --- |
Biogen Inc | 28.2B | 24.0x | -18.14% |
Grifols SA | 7.2B | 35.8x | --- |
Beigene Ltd | 26.5B | -45.5x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $25.7B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.66 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -4.2x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.